tecovirimat

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

TPOXX — SIGA TECHNOLOGIES, approved 2024-06-03 (NDA214518).

Most reported adverse events (US / FAERS)

114 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

drug resistance

19

headache

14

nausea

14

fatigue

12

diarrhoea

Medicines containing this active substance

1 medicines

Tecovirimat SIGA

Authorised

🇺🇸 Also approved in the US (FDA)

TPOXX — SIGA TECHNOLOGIES, approved 2024-06-03 (NDA214518).

Most reported adverse events (US / FAERS)

114 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

drug resistance

19

headache

14

nausea

14

fatigue

12

diarrhoea

10

acute kidney injury

6

alanine aminotransferase increased

6

decreased appetite

5

off label use

5

abdominal pain

4

dizziness

4

drug ineffective

4

skin lesion

4

vomiting

4

abdominal discomfort

3